181 related articles for article (PubMed ID: 153333)
1. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.
Webster GF; Leyden JJ; Norman ME; Nilsson UR
Infect Immun; 1978 Nov; 22(2):523-9. PubMed ID: 153333
[TBL] [Abstract][Full Text] [Related]
2. Complement activation in acne vulgaris: consumption of complement by comedones.
Webster GF; Leyden JJ; Nilsson UR
Infect Immun; 1979 Oct; 26(1):183-6. PubMed ID: 159261
[TBL] [Abstract][Full Text] [Related]
3. Cytotaxin production by comedonal bacteria (Propionibacterium acnes, Propionibacterium granulosum and Staphylococcus epidermidis).
Puhvel SM; Sakamoto M
J Invest Dermatol; 1980 Jan; 74(1):36-9. PubMed ID: 6444322
[TBL] [Abstract][Full Text] [Related]
4. The effects of tetracyclines and erythromycin on complement activation in vitro.
Ingham E
Acta Derm Venereol; 1990; 70(6):531-4. PubMed ID: 1981435
[TBL] [Abstract][Full Text] [Related]
5. Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris.
Knop J; Bossecker T; Kövary PM
Arch Dermatol Res; 1982; 274(3-4):267-75. PubMed ID: 6219635
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte activating factor released from Propionibacterium acnes. A possible mediator of inflammation in acne vulgaris.
Pulverer G; Roszkowski W; Beuth HJ; Ko HL; Quie P
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):246-51. PubMed ID: 2975904
[TBL] [Abstract][Full Text] [Related]
7. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
Załuga E
Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
[TBL] [Abstract][Full Text] [Related]
8. Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.
Webster GF; Nilsson UR; McArthur WP
Inflammation; 1981 Jun; 5(2):165-76. PubMed ID: 7275277
[TBL] [Abstract][Full Text] [Related]
9. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne.
Vowels BR; Yang S; Leyden JJ
Infect Immun; 1995 Aug; 63(8):3158-65. PubMed ID: 7542639
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous visualization of Propionibacterium acnes and Propionibacterium granulosum with immunofluorescence and fluorescence in situ hybridization.
Jahns AC; Oprica C; Vassilaki I; Golovleva I; Palmer RH; Alexeyev OA
Anaerobe; 2013 Oct; 23():48-54. PubMed ID: 23896347
[TBL] [Abstract][Full Text] [Related]
11. Acne: a review of immunologic and microbiologic factors.
Burkhart CG; Burkhart CN; Lehmann PF
Postgrad Med J; 1999 Jun; 75(884):328-31. PubMed ID: 10435165
[TBL] [Abstract][Full Text] [Related]
12. Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients.
Webster GF; Leyden JJ; Tsai CC; Baehni P; McArthur WP
J Invest Dermatol; 1980 Jun; 74(6):398-401. PubMed ID: 6445921
[TBL] [Abstract][Full Text] [Related]
13. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity.
Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B
Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673
[TBL] [Abstract][Full Text] [Related]
14. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
Whiteside JA; Voss JG
J Invest Dermatol; 1973 Feb; 60(2):94-7. PubMed ID: 4266325
[No Abstract] [Full Text] [Related]
15. Activation of components of the alternative pathway of complement by Propionibacterium acnes cell wall carbohydrate.
Webster GF; McArthur WP
J Invest Dermatol; 1982 Sep; 79(3):137-40. PubMed ID: 6809840
[TBL] [Abstract][Full Text] [Related]
16. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
Basal E; Jain A; Kaushal GP
J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
[TBL] [Abstract][Full Text] [Related]
18. Delayed skin test reactivity to Propionibacterium acnes correlates with severity of inflammation in acne vulgaris.
Kersey P; Sussman M; Dahl M
Br J Dermatol; 1980 Dec; 103(6):651-5. PubMed ID: 6450605
[TBL] [Abstract][Full Text] [Related]
19.
Bronnec V; Eilers H; Jahns AC; Omer H; Alexeyev OA
Front Cell Infect Microbiol; 2021; 11():809792. PubMed ID: 35155271
[TBL] [Abstract][Full Text] [Related]
20. Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism.
Akamatsu H; Niwa Y; Kurokawa I; Masuda R; Nishijima S; Asada Y
Arch Dermatol Res; 1991; 283(8):524-8. PubMed ID: 1838472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
